Regulus Therapeutics Inc (RGLS)

Feb 21, 2025

Regulus Therapeutics Inc. (RGLS): Among the Cheapest Stocks Insiders Are Buying Recently - Insider Monkey

Feb 21, 2025

Feb 20, 2025

10 Cheapest Stocks Insiders Are Buying Recently - Insider Monkey

Feb 20, 2025

Feb 09, 2025

Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives $10.80 Average PT from Analysts - MarketBeat

Feb 09, 2025

Feb 07, 2025

Pre-market Movers In Healthcare Sector: ACER, AZRX, RUBY, ADTX, RGLS… - RTTNews

Feb 07, 2025

Feb 05, 2025

Checking in on Regulus Therapeutics Inc (RGLS) after recent insiders movement - Knox Daily

Feb 05, 2025

Feb 05, 2025

Is Regulus Therapeutics Inc (NASDAQ: RGLS) Stock Worth Investing In for High Returns? - Marketing Sentinel

Feb 05, 2025

Feb 04, 2025

RGLS’s price-to-free cash flow ratio: A closer look at its relevance - US Post News

Feb 04, 2025

Feb 04, 2025

Regulus Therapeutics Inc (RGLS) Stock: A Year of Highs and Lows - The InvestChronicle

Feb 04, 2025

Feb 04, 2025

Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Morningstar

Feb 04, 2025

Feb 03, 2025

Regulus Therapeutics Inc. (NASDAQ:RGLS) Director David Baltimore Acquires 19,610 Shares - MarketBeat

Feb 03, 2025

Feb 03, 2025

Insider Buying: Regulus Therapeutics Inc. (NASDAQ:RGLS) CEO Acquires 50,000 Shares of Stock - MarketBeat

Feb 03, 2025

Feb 03, 2025

JPMorgan Chase & Co. Raises Stake in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World

Feb 03, 2025

Feb 02, 2025

Insider Moves Spark Interest: Is Regulus Therapeutics Set for a Comeback? - Jomfruland.net

Feb 02, 2025

Feb 02, 2025

Insiders Give Up US$8.7k As Regulus Therapeutics Stock Drops To US$1.00 - Yahoo Finance

Feb 02, 2025

Feb 02, 2025

CEO & Director of Regulus Therapeutics Joseph Hagan Buys 24% More Shares - Simply Wall St

Feb 02, 2025

Feb 01, 2025

Insider Buying: David Baltimore Acquires Shares of Regulus Thera - GuruFocus.com

Feb 01, 2025

Jan 31, 2025

Insider Buying: Joseph Hagan Acquires 50,000 Shares of Regulus T - GuruFocus.com

Jan 31, 2025

Jan 30, 2025

Regulus stock tumbles 24% amid study, regulatory updates - MSN

Jan 30, 2025

Jan 29, 2025

REVB Start 1B Trial and Announces Split - MSN

Jan 29, 2025

Jan 29, 2025

Regulus Therapeutics Shares Drop 24% Despite Positive ADPKD Tria - GuruFocus.com

Jan 29, 2025

Jan 29, 2025

Regulus Therapeutics Shares Drop 24% Despite Positive ADPKD Trial Data - Yahoo Finance

Jan 29, 2025

Jan 29, 2025

Regulus Therapeutics Kidney Disease Treatment Shows Response in Early-stage Trial -- Shares Fall - Marketscreener.com

Jan 29, 2025

Jan 29, 2025

Regulus stock tumbles 24% amid study, regulatory updates (RGLS:NASDAQ) - Seeking Alpha

Jan 29, 2025

Jan 29, 2025

Regulus reports progress in ADPKD trial and FDA talks - MSN

Jan 29, 2025

Jan 29, 2025

Regulus Therapeutics Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen (RGLS8429) - Citizentribune

Jan 29, 2025

Jan 29, 2025

Regulus Therapeutics (RGLS) Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen - StreetInsider.com

Jan 29, 2025

Jan 28, 2025

Regulus Therapeutics stock hits 52-week low at $1.16 - MSN

Jan 28, 2025

Jan 28, 2025

Regulus Therapeutics stock hits 52-week low at $1.16 By Investing.com - Investing.com South Africa

Jan 28, 2025

Jan 24, 2025

Barclays PLC Grows Stake in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World

Jan 24, 2025

Jan 16, 2025

Regulus Therapeutics CFO sells shares worth $55,333 By Investing.com - Investing.com South Africa

Jan 16, 2025

Jan 16, 2025

Jane Street Group LLC Takes $46,000 Position in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World

Jan 16, 2025

Jan 15, 2025

Regulus Therapeutics president sells $39,721 in stock By Investing.com - Investing.com Australia

Jan 15, 2025

Jan 15, 2025

Regulus Therapeutics CEO sells shares worth $160,494 By Investing.com - Investing.com Canada

Jan 15, 2025

Jan 15, 2025

Regulus therapeutics executive sells shares worth $55,119 By Investing.com - Investing.com Nigeria

Jan 15, 2025

Jan 15, 2025

Insider Selling: Regulus Therapeutics Inc. (NASDAQ:RGLS) Insider Sells 31,445 Shares of Stock - MarketBeat

Jan 15, 2025

Jan 15, 2025

Joseph P. Hagan Sells 115,290 Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) Stock - MarketBeat

Jan 15, 2025

Jan 15, 2025

Christopher Ray Aker Sells 38,547 Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) Stock - MarketBeat

Jan 15, 2025

Jan 15, 2025

Regulus Therapeutics Inc. (NASDAQ:RGLS) CFO Crispina Calsada Sells 38,716 Shares - MarketBeat

Jan 15, 2025

Jan 15, 2025

Regulus therapeutics executive sells shares worth $55,119 - Investing.com India

Jan 15, 2025

Jan 15, 2025

Regulus Therapeutics president sells $39,721 in stock - Investing.com

Jan 15, 2025

Jan 15, 2025

Regulus Therapeutics CFO sells shares worth $55,333 - Investing.com

Jan 15, 2025

Jan 15, 2025

Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives $10.80 Consensus PT from Analysts - Defense World

Jan 15, 2025

Jan 12, 2025

Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Jan 12, 2025

Jan 09, 2025

Geode Capital Management LLC Lowers Stock Holdings in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World

Jan 09, 2025

Jan 09, 2025

Regulus Therapeutics Inc. (NASDAQ:RGLS) Shares Acquired by Barclays PLC - Defense World

Jan 09, 2025

Jan 02, 2025

Regulus Therapeutics Inc. (NASDAQ:RGLS) Shares Acquired by State Street Corp - Defense World

Jan 02, 2025

Dec 31, 2024

This Biotech Wasted No Time Stealing The Premarket Show - MSN

Dec 31, 2024

Dec 23, 2024

Regulus Therapeutics Announces Completion of Enrollment in Secon - GuruFocus.com

Dec 23, 2024

Dec 21, 2024

Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives $10.80 Average Target Price from Analysts - Defense World

Dec 21, 2024

Dec 21, 2024

Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences - The Eastern Progress Online

Dec 21, 2024

Dec 19, 2024

Institutional investors may overlook Regulus Therapeutics Inc.'s (NASDAQ:RGLS) recent US$12m market cap drop as long-term gains remain positive - Simply Wall St

Dec 19, 2024